Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders
- 1 May 2003
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 110 (5) , 1061-1065
- https://doi.org/10.1016/s0161-6420(03)00092-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mycophenolic acid in psoriasisBritish Journal of Dermatology, 2006
- PROMISING EARLY OUTCOMES WITH A NOVEL, COMPLETE STEROID AVOIDANCE IMMUNOSUPPRESSION PROTOCOL IN PEDIATRIC RENAL TRANSPLANTATION1Transplantation, 2001
- RANDOMIZED TRIAL OF TACROLIMUS PLUS MYCOPHENOLATE MOFETIL OR AZATHIOPRINE VERSUS CYCLOSPORINE ORAL SOLUTION (MODIFIED) PLUS MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION: RESULTS AT 2 YEARS1Transplantation, 2001
- Erste klinische Erfahrungen mit Mycophenolatmofetil bei der immunsuppressiven Therapie des okulären Pemphigoids1Klinische Monatsblätter für Augenheilkunde, 2001
- Treatment of systemic lupus erythematosus with mycophenolate mofetilLupus, 2001
- Perspective on future therapy of vasculitis.Current Rheumatology Reports, 2000
- Pharmacodynamic Monitoring of Mycophenolate Mofetilcclm, 2000
- Mycophenolate mofetil: A useful immunosuppressive in inflammatory eye diseaseOphthalmology, 1999
- Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolismExperimental Eye Research, 1995
- International Uveitis Study Group Recommendations for the Evaluation of Intraocular Inflammatory DiseaseAmerican Journal of Ophthalmology, 1987